Gregory Duncan
Chief Executive Officer at VIRIOS THERAPEUTICS, INC.
Net worth: 26 202 $ as of 29/04/2024
Gregory Duncan active positions
| Companies | Position | Start | End |
|---|---|---|---|
| VIRIOS THERAPEUTICS, INC. | Chief Executive Officer | 31/03/2020 | - |
| Chairman | 31/12/2017 | - | |
| CORMEDIX INC. | Director/Board Member | 01/11/2020 | - |
| Independent Dir/Board Member | 01/11/2020 | - | |
Center for Global Health Innovation, Inc.
 Center for Global Health Innovation, Inc. BiotechnologyHealth Technology Center for Global Health Innovation, Inc. is a member of Georgia Bio, a non-profit life sciences association in Georgia. The non-profit company is based in Atlanta, GA. Georgia Bio works with various organizations to shape public policy, improve access to innovative technologies, and grow Georgia's life sciences economy. The CEO of the company is Maria Thacker-Goethe. | Director/Board Member | - | - |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | 16/08/2011 | - |
| American Psychiatric Foundation | Director/Board Member | - | - |
| Southeast BIO | Director/Board Member | - | - |
| Biotie Therapeutics Corp. | Director/Board Member | - | - |
Career history of Gregory Duncan
Former positions of Gregory Duncan
| Companies | Position | Start | End |
|---|---|---|---|
Celtaxsys, Inc.
 Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Director/Board Member | 07/01/2014 | 29/02/2020 |
| Chief Executive Officer | 07/01/2014 | 29/02/2020 | |
| President | 07/01/2014 | 29/02/2020 | |
| UCB | Corporate Officer/Principal | 16/08/2011 | 31/01/2013 |
| ░░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Gregory Duncan
| Emory University | Masters Business Admin |
| State University of New York at Albany | Undergraduate Degree |
Statistics
International
| United States | 11 |
| Belgium | 2 |
| Finland | 2 |
Operational
| Director/Board Member | 7 |
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 7 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| UCB | Health Technology |
| VIRIOS THERAPEUTICS, INC. | Health Technology |
| CORMEDIX INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| Private companies | 6 |
|---|---|
Center for Global Health Innovation, Inc.
Center for Global Health Innovation, Inc. BiotechnologyHealth Technology Center for Global Health Innovation, Inc. is a member of Georgia Bio, a non-profit life sciences association in Georgia. The non-profit company is based in Atlanta, GA. Georgia Bio works with various organizations to shape public policy, improve access to innovative technologies, and grow Georgia's life sciences economy. The CEO of the company is Maria Thacker-Goethe. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
| American Psychiatric Foundation | |
Celtaxsys, Inc.
Celtaxsys, Inc. Pharmaceuticals: MajorHealth Technology Celtaxsys, Inc. operates as a clinical-stage drug discovery and development company that focuses on novel therapeutics to treat patients suffering from inflammatory diseases. It offers CTX-4430, a small-molecule drug that targets the enzyme Leukotriene A4 hydrolase in immune cells for the treatment of cystic fibrosis and moderately severe acne diseases. The company was founded by William P. Reddick in 2005 and is headquartered in Atlanta, GA. | Health Technology |
| Southeast BIO | |
| Biotie Therapeutics Corp. |
- Stock Market
- Insiders
- Gregory Duncan
- Experience
